Global Monogenetic Disorders Testing Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Monogenetic Disorders Testing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Monogenetic Disorders Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Carrier Testing
  • 1.4.3 Diagnostic Testing
  • 1.4.4 New-Born Screening
  • 1.4.5 Predictive & Pre-Symptomatic Testing
  • 1.4.6 Prenatal Testing
  • 1.4.7 Others
• 1.5 Market by Application
  • 1.5.1 Global Monogenetic Disorders Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Specialized Clinics
  • 1.5.4 Ambulatory Surgical Centers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Monogenetic Disorders Testing Market Perspective (2015-2026)
• 2.2 Global Monogenetic Disorders Testing Growth Trends by Regions
  • 2.2.1 Monogenetic Disorders Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Monogenetic Disorders Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Monogenetic Disorders Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Monogenetic Disorders Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Monogenetic Disorders Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Monogenetic Disorders Testing Players by Market Size
  • 3.1.1 Global Top Monogenetic Disorders Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Monogenetic Disorders Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Monogenetic Disorders Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Monogenetic Disorders Testing Market Concentration Ratio
  • 3.2.1 Global Monogenetic Disorders Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Monogenetic Disorders Testing Revenue in 2019
• 3.3 Monogenetic Disorders Testing Key Players Head office and Area Served
• 3.4 Key Players Monogenetic Disorders Testing Product Solution and Service
• 3.5 Date of Enter into Monogenetic Disorders Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Monogenetic Disorders Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Monogenetic Disorders Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Monogenetic Disorders Testing Market Size by Application (2015-2020)
• 5.2 Global Monogenetic Disorders Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Monogenetic Disorders Testing Market Size (2015-2020)
• 6.2 Monogenetic Disorders Testing Key Players in North America (2019-2020)
• 6.3 North America Monogenetic Disorders Testing Market Size by Type (2015-2020)
• 6.4 North America Monogenetic Disorders Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Monogenetic Disorders Testing Market Size (2015-2020)
• 7.2 Monogenetic Disorders Testing Key Players in Europe (2019-2020)
• 7.3 Europe Monogenetic Disorders Testing Market Size by Type (2015-2020)
• 7.4 Europe Monogenetic Disorders Testing Market Size by Application (2015-2020)

8 China

• 8.1 China Monogenetic Disorders Testing Market Size (2015-2020)
• 8.2 Monogenetic Disorders Testing Key Players in China (2019-2020)
• 8.3 China Monogenetic Disorders Testing Market Size by Type (2015-2020)
• 8.4 China Monogenetic Disorders Testing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Monogenetic Disorders Testing Market Size (2015-2020)
• 9.2 Monogenetic Disorders Testing Key Players in Japan (2019-2020)
• 9.3 Japan Monogenetic Disorders Testing Market Size by Type (2015-2020)
• 9.4 Japan Monogenetic Disorders Testing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Monogenetic Disorders Testing Market Size (2015-2020)
• 10.2 Monogenetic Disorders Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Monogenetic Disorders Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Monogenetic Disorders Testing Market Size by Application (2015-2020)

11 India

• 11.1 India Monogenetic Disorders Testing Market Size (2015-2020)
• 11.2 Monogenetic Disorders Testing Key Players in India (2019-2020)
• 11.3 India Monogenetic Disorders Testing Market Size by Type (2015-2020)
• 11.4 India Monogenetic Disorders Testing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Monogenetic Disorders Testing Market Size (2015-2020)
• 12.2 Monogenetic Disorders Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Monogenetic Disorders Testing Market Size by Type (2015-2020)
• 12.4 Central & South America Monogenetic Disorders Testing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Celera Group
  • 13.1.1 Celera Group Company Details
  • 13.1.2 Celera Group Business Overview
  • 13.1.3 Celera Group Monogenetic Disorders Testing Introduction
  • 13.1.4 Celera Group Revenue in Monogenetic Disorders Testing Business (2015-2020))
  • 13.1.5 Celera Group Recent Development
• 13.2 Abbott
  • 13.2.1 Abbott Company Details
  • 13.2.2 Abbott Business Overview
  • 13.2.3 Abbott Monogenetic Disorders Testing Introduction
  • 13.2.4 Abbott Revenue in Monogenetic Disorders Testing Business (2015-2020)
  • 13.2.5 Abbott Recent Development
• 13.3 Thermo Fisher Scientific
  • 13.3.1 Thermo Fisher Scientific Company Details
  • 13.3.2 Thermo Fisher Scientific Business Overview
  • 13.3.3 Thermo Fisher Scientific Monogenetic Disorders Testing Introduction
  • 13.3.4 Thermo Fisher Scientific Revenue in Monogenetic Disorders Testing Business (2015-2020)
  • 13.3.5 Thermo Fisher Scientific Recent Development
• 13.4 ELITech Group
  • 13.4.1 ELITech Group Company Details
  • 13.4.2 ELITech Group Business Overview
  • 13.4.3 ELITech Group Monogenetic Disorders Testing Introduction
  • 13.4.4 ELITech Group Revenue in Monogenetic Disorders Testing Business (2015-2020)
  • 13.4.5 ELITech Group Recent Development
• 13.5 Quest
  • 13.5.1 Quest Company Details
  • 13.5.2 Quest Business Overview
  • 13.5.3 Quest Monogenetic Disorders Testing Introduction
  • 13.5.4 Quest Revenue in Monogenetic Disorders Testing Business (2015-2020)
  • 13.5.5 Quest Recent Development
• 13.6 AutoGenomics
  • 13.6.1 AutoGenomics Company Details
  • 13.6.2 AutoGenomics Business Overview
  • 13.6.3 AutoGenomics Monogenetic Disorders Testing Introduction
  • 13.6.4 AutoGenomics Revenue in Monogenetic Disorders Testing Business (2015-2020)
  • 13.6.5 AutoGenomics Recent Development
• 13.7 PerkinElmer
  • 13.7.1 PerkinElmer Company Details
  • 13.7.2 PerkinElmer Business Overview
  • 13.7.3 PerkinElmer Monogenetic Disorders Testing Introduction
  • 13.7.4 PerkinElmer Revenue in Monogenetic Disorders Testing Business (2015-2020)
  • 13.7.5 PerkinElmer Recent Development
• 13.8 Roche
  • 13.8.1 Roche Company Details
  • 13.8.2 Roche Business Overview
  • 13.8.3 Roche Monogenetic Disorders Testing Introduction
  • 13.8.4 Roche Revenue in Monogenetic Disorders Testing Business (2015-2020)
  • 13.8.5 Roche Recent Development
• 13.9 Bio-Rad
  • 13.9.1 Bio-Rad Company Details
  • 13.9.2 Bio-Rad Business Overview
  • 13.9.3 Bio-Rad Monogenetic Disorders Testing Introduction
  • 13.9.4 Bio-Rad Revenue in Monogenetic Disorders Testing Business (2015-2020)
  • 13.9.5 Bio-Rad Recent Development
• 13.10 Transgenomic
  • 13.10.1 Transgenomic Company Details
  • 13.10.2 Transgenomic Business Overview
  • 13.10.3 Transgenomic Monogenetic Disorders Testing Introduction
  • 13.10.4 Transgenomic Revenue in Monogenetic Disorders Testing Business (2015-2020)
  • 13.10.5 Transgenomic Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer